Group One Trading
CTXR icon

Group One Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Group One Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$568 Sell
1,070
-481
-31% -$284 ﹤0.01% 7238
2026
Q2 		$938 Buy
+1,551
New +$1.05K ﹤0.01% 7194
2025
Q3 		– Sell
-649
Closed -$1.03K – 8515
2025
Q2 		$1.03K Sell
649
-2,693
-81% -$2.47K ﹤0.01% 7553
2025
Q1 		$4.98K Sell
3,342
-1,475
-31% -$3.53K ﹤0.01% 6650
2024
Q4 		$19.3K Buy
4,817
+3,991
+483% +$26.9K ﹤0.01% 5711
2024
Q3 		$10.3K Sell
826
-128
-13% -$2.15K ﹤0.01% 5588
2024
Q2 		$13.9K Buy
954
+171
+22% +$3.06K ﹤0.01% 5453
2024
Q1 		$17.6K Sell
783
-241
-24% -$4.4K ﹤0.01% 5523
2023
Q4 		$19.4K Hold
1,024
– – ﹤0.01% 5771
2023
Q3 		$17.5K Buy
+1,024
New +$24.3K ﹤0.01% 5979
2023
Q2 		– Sell
-1,956
Closed -$64.4K – 7725
2023
Q1 		$57.2K Sell
1,956
-423
-18% -$12.2K ﹤0.01% 4751
2022
Q4 		$47K Buy
2,379
+652
+38% +$17.8K ﹤0.01% 5043
2022
Q3 		$52K Buy
+1,727
New +$47.5K ﹤0.01% 5377

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Miller Financial Services
Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return
Asset Advisory Group
Asset Advisory Group Kinnelon, New Jersey $232M AUM 16.51% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Quent Capital
Quent Capital New York $1.67B AUM 19.79% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Group One Trading's CTXR Position: Q3 2026 in Review

Group One Trading reduced its Citius Pharmaceuticals (CTXR) stake by 31% in Q3 2026, selling an estimated $284 and leaving 1,070 shares worth $568. The position accounts for ﹤0.01% of the portfolio, ranked #7238.

Group One Trading first reported a position in CTXR in Q3 2022 and has held it in 13 quarters since. The position peaked at $57.2K in Q1 2023. 15 funds tracked by Wall St. Rank hold CTXR as of Q3 2026.

  • Group One Trading held 1,070 shares of Citius Pharmaceuticals worth $568 as of Q3 2026.
  • Group One Trading sold 481 Citius Pharmaceuticals shares in Q3 2026, an estimated $284.
  • Citius Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7238 holding.
  • Group One Trading first reported a position in Citius Pharmaceuticals in Q3 2022 and has held it in 13 quarters since.
  • Group One Trading's Citius Pharmaceuticals position peaked at $57.2K in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.